Rapt Therapeutics EPS Basic from Discontinued Operations (Annual) Insights

Rapt Therapeutics, Inc. (RAPT)

57.54 +22.44 (+63.93%) USD | NASDAQ | Jan 20, 16:00

57.57 +0.03 (+0.05%) After-Hours: 17:31

View EPS Basic from Discontinued Operations (Annual) for RAPT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Basic from Discontinued Operations (Annual) Chart

Start Trial

View Historical Data

Start Trial

View EPS Basic from Discontinued Operations (Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Basic from Discontinued Operations (Annual) Benchmarks

Start Trial

Replimune Group, Inc.	--
Olema Pharmaceuticals, Inc.	--
NovaBay Pharmaceuticals, Inc.	Upgrade
Palatin Technologies, Inc.	--
Theriva Biologics, Inc.	--